BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19954913)

  • 21. Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection.
    Hayes JT; David EA; Qi L; Chen AM; Daly ME
    Clin Lung Cancer; 2015 Sep; 16(5):379-84. PubMed ID: 25737143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis.
    Choi YW; Munden RF; Erasmus JJ; Park KJ; Chung WK; Jeon SC; Park CK
    Radiographics; 2004; 24(4):985-97; discussion 998. PubMed ID: 15256622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer.
    Takeda A; Kunieda E; Fujii H; Yokosuka N; Aoki Y; Oooka Y; Oku Y; Ohashi T; Sanuki N; Mizuno T; Ozawa Y
    Lung Cancer; 2013 Mar; 79(3):248-53. PubMed ID: 23246123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Forcing lateral electron disequilibrium to spare lung tissue: a novel technique for stereotactic body radiation therapy of lung cancer.
    Disher B; Hajdok G; Gaede S; Mulligan M; Battista JJ
    Phys Med Biol; 2013 Oct; 58(19):6641-62. PubMed ID: 24018569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiographic response and clinical toxicity following SBRT for stage I lung cancer.
    Bradley J
    J Thorac Oncol; 2007 Jul; 2(7 Suppl 3):S118-24. PubMed ID: 17603307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity.
    Ong CL; Palma D; Verbakel WF; Slotman BJ; Senan S
    Radiother Oncol; 2010 Dec; 97(3):431-6. PubMed ID: 20971523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiomics-based Assessment of Radiation-induced Lung Injury After Stereotactic Body Radiotherapy.
    Moran A; Daly ME; Yip SSF; Yamamoto T
    Clin Lung Cancer; 2017 Nov; 18(6):e425-e431. PubMed ID: 28623121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation Pneumonitis Changes over Time after Stereotactic Body Radiation Therapy for Lung Tumors: Post-treatment Cavity (Sunny-side-up Egg-like) Changes.
    Maebayashi T; Ishibashi N; Aizawa T; Sakaguchi M; Sato T; Kawamori J; Tanaka Y
    Anticancer Res; 2016 Oct; 36(10):5563-5570. PubMed ID: 27798931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
    Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
    Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic body radiation therapy for unbiopsied early-stage lung cancer: a multi-institutional analysis.
    Harkenrider MM; Bertke MH; Dunlap NE
    Am J Clin Oncol; 2014 Aug; 37(4):337-42. PubMed ID: 23660597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers.
    Neri S; Takahashi Y; Terashi T; Hamakawa H; Tomii K; Katakami N; Kokubo M
    J Thorac Oncol; 2010 Dec; 5(12):2003-7. PubMed ID: 21102262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy.
    Yamashita H; Kobayashi-Shibata S; Terahara A; Okuma K; Haga A; Wakui R; Ohtomo K; Nakagawa K
    Radiat Oncol; 2010 May; 5():32. PubMed ID: 20459699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT patterns and serial CT Changes in lung Cancer patients post stereotactic body radiotherapy (SBRT).
    Al-Umairi R; Tarique U; Moineddin R; Jimenez-Juan L; Kha LC; Cheung P; Oikonomou A
    Cancer Imaging; 2022 Sep; 22(1):51. PubMed ID: 36114585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors.
    Matsuo Y; Nagata Y; Mizowaki T; Takayama K; Sakamoto T; Sakamoto M; Norihisa Y; Hiraoka M
    Int J Clin Oncol; 2007 Oct; 12(5):356-62. PubMed ID: 17929117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
    Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
    Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
    Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
    Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
    Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
    Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning.
    Coon D; Gokhale AS; Burton SA; Heron DE; Ozhasoglu C; Christie N
    Clin Lung Cancer; 2008 Jul; 9(4):217-21. PubMed ID: 18650169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer.
    Hoopes DJ; Tann M; Fletcher JW; Forquer JA; Lin PF; Lo SS; Timmerman RD; McGarry RC
    Lung Cancer; 2007 May; 56(2):229-34. PubMed ID: 17353064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
    Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.